Japan's Otsuka Pharma has agreed to take control of US biotech Jnana Therapeutics in a deal that will give it rights to a clinical-stage candidate for the rare metabolic disorder phenylketonuria (PKU) ...
IRVINE, CA –The Center for Inner Resources Development–North America (CIRD-NA) will host the 2025 edition of Jnana Yajna, a series of spiritual programs led by Indian spiritual teachers in three U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback